Altimmune (ALT) Other Operating Expenses (2010 - 2023)

Altimmune (ALT) has 9 years of Other Operating Expenses data on file, last reported at $12.4 million in Q4 2023.

• Other Operating Expenses for Q4 2023 came in at $12.4 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2024 was $12.4 million (changed N/A YoY), and the FY2023 annual result was $12.4 million, changed N/A from the prior year.
• Other Operating Expenses advanced to $12.4 million in Q4 2023 per ALT's latest filing, from $3.3 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $12.4 million in Q4 2023 and troughed at $1.0 million in Q3 2019.
• A 3-year average of $6.2 million and a median of $5.7 million in 2021 frame the typical range for Other Operating Expenses.
• On a YoY basis, Other Operating Expenses climbed as much as 102.4% in 2019 and fell as far as 102.4% in 2019.
• A 3-year view of Other Operating Expenses shows it stood at $1.0 million in 2019, then surged by 230.0% to $3.3 million in 2021, then soared by 276.33% to $12.4 million in 2023.
• Business Quant data shows ALT's Other Operating Expenses at $12.4 million in Q4 2023, $3.3 million in Q4 2021, and $8.1 million in Q2 2021.